EQUITY RESEARCH MEMO
Thermidas
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)65/100
Thermidas is a Finnish digital health company founded in 2017 and headquartered in Helsinki, specializing in temperature monitoring and fever management solutions. The company operates at the intersection of diagnostics and digital health, leveraging data-driven insights to improve patient outcomes. By focusing on continuous temperature monitoring, Thermidas aims to enhance early detection and management of febrile illnesses, reducing complications and healthcare costs. The company's product line targets both clinical and home settings, addressing a critical need in infection management, especially in the post-pandemic era where remote patient monitoring has become increasingly important.
Upcoming Catalysts (preview)
- Q3 2026FDA clearance for next-generation continuous temperature monitor60% success
- Q3 2026Partnership with a major European hospital network for pilot deployment70% success
- Q3 2026Publication of clinical study demonstrating impact on sepsis detection50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)